awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33529392-F5DA4C82-53AA-40EE-A453-04232FFEEDA6
Q33529392-F5DA4C82-53AA-40EE-A453-04232FFEEDA6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33529392-F5DA4C82-53AA-40EE-A453-04232FFEEDA6
Anti-EphA2 Antibodies with Distinct In Vitro Properties Have Equal In Vivo Efficacy in Pancreatic Cancer.
P2860
Q33529392-F5DA4C82-53AA-40EE-A453-04232FFEEDA6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33529392-F5DA4C82-53AA-40EE-A453-04232FFEEDA6
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
c71e148cb639210955f260647dc585e4930f417d
P2860
Effects of dasatinib on EphA2 receptor tyrosine kinase activity and downstream signalling in pancreatic cancer.